2019

On Friday, June 28, 2019 the Centers for Medicare & Medicaid Services (CMS) released the 2018 Open Payments Data which covers…

The Department of Justice (“DOJ”) announced that it has reached an agreement with Almirall, LLC, formerly Aqua Pharmaceuticals,…

On Friday June 27, 2019, CMS published the 2018 Open Payments data.  Overall there was little change with the exception that…

A federal judge ordered HHS to come up with a remedial measure that would address hospital payment cuts under Medicare's 340B drug…

Recently, it was announced that Heritage Pharmaceuticals, Inc., a generic pharmaceutical company, was charged with conspiring with…

On June 24, 2019, Maine Governor Janet Mills signed a four-bill prescription drug reform package into law that would allow the…

As we have previously reported, the federal government has taken an acute interest in pharmaceutical drug pricing, resulting in a…

On June 14, 2019, several pharmaceutical companies filed suit against the Department of Health and Human Services (“HHS”), seeking…

The outcomes of a recent continuing medical education (CME) program demonstrated that prior to the participating in the education…

Colorado Governor Jared S. Polis signed an Act into law that starting August 2nd 2019 requires drug manufacturers to make certain…